Spinal fusion implant

Information

  • Patent Grant
  • 9320614
  • Patent Number
    9,320,614
  • Date Filed
    Thursday, May 28, 2015
    9 years ago
  • Date Issued
    Tuesday, April 26, 2016
    8 years ago
Abstract
The present invention provides a device and methodology for use in spinal fusion surgeries. An implant is proved for forming a rigid structure between adjoining vertebrae in a patient. The implant is a cage defined by at least a first end, second end, first side, and second side surface, wherein first and second side surfaces extend substantially parallel to each other to span a space between adjoining vertebrae and first and second ends interconnect said first side surface and second side surface. The cage incorporates one or more flexible joints that allow the cage to be deformed for insertion into a patient. The ability to deform the cage allows a greater ease and flexibility in inserting and positioning the implant.
Description
FIELD OF THE INVENTION

The present invention relates to a spinal implant, the accompanying instrumentation and the method of use of both. More particularly, the present invention relates to a device and instrumentation for use in a minimally invasive vertebral fusion procedure.


BACKGROUND OF THE INVENTION

Spinal fusion surgeries that use bone graft material to promote specific vertebrae to grow together into a solid and stable construct are a common method of treating patients with severe back pain. In posterior lumbar interbody fusion (PLIF), damaged disk material is removed and one or more implants are inserted posteriorly to promote bone growth from vertebral body to vertebral body to bridge the gap left by the removed material.


A larger implant better fills the intervertibral space and distributes compressive loads. A larger implant also reduces the need for multiple implants, which may require multiple approaches to insertion and placement. However, Minimally Invasive Surgery (MIS) necessitates the use of less invasive techniques that use smaller access portals to perform the fusion that limit the size of implant that can be used.


An example of this is Transforaminal Posterial Lumbar Interbody Fusion (T-PLIF), which is a variation of the PLIF technique. In this procedure, an implant is inserted through a unilateral or bilateral posterior approach. The T-PLIF technique avoids damage to the nerve structures such as the dura, cauda equine, and the nerve root, but the transforaminal window through which the procedure is performed is limited making the insertion and positioning of the implant difficult.


Thus what is needed is an implant that can suitably fill the intervertebral space but can be inserted and positioned through a small access portal, such as the transforaminal window used in a T-PLIF procedure.


SUMMARY OF THE INVENTION

The present invention provides a device and methodology for use in spinal fusion surgeries. An implant, instrumentation, and methodology are provided for forming a rigid structure between adjoining vertebrae in a patient. The implant is a cage defined by at least a first end, second end, first side, and second side surface. The cage incorporates one or more flexible joints that allow the cage to be deformed for insertion into a patient. The ability to deform the cage allows a greater ease and flexibility in inserting and positioning the implant. For example, a larger implant can to be used in minimally invasive surgery (MIS) techniques because the cage can be transformed to a smaller profile to pass through the smaller access ports used in minimally invasive surgery.


In accordance with one aspect of the present invention, an implant is provided for forming a rigid structure between adjoining vertebrae in a patient. The implant includes a cage defined by at least a first end, second end, first side, and second side surface, and one or more flexible joints incorporated into the cage allowing the cage to be deformed for insertion into a patient.


In certain embodiments, the implant further comprises surface configurations on at least one of the first and second side surfaces of the cage for slidably attaching the implant to an insertion guide. The one or more flexible joints of the implant allow the cage to conform to the shape of the insertion guide as the implant is slid along the length of the guide.


In accordance with another aspect of the present invention, a method is provided for fusing vertebrae of a patient. The method involves the steps of providing an implant of the present invention, and inserting the implant into the space between adjoining vertebrae in a patient to form a rigid structure between the adjoining vertebrae.


In accordance with another embodiment, a system is proved for forming a rigid structure between adjoining vertebrae in a patient. The system includes an implant of the present invention having surface configurations on at least one of the first and second side surfaces of the cage for slidably attaching the implant to an insertion guide; and an insertion guide configured to interface with the surface configurations of the implant for positioning the implant during insertion.


In accordance with another aspect of the present invention, a method is provided for fusing vertebrae of a patient. The method involves providing a system of the present invention comprising a implant with surface configurations and an insertion guide; inserting the insertion guide into the space between adjoining vertebrae in the patient; and sliding the implant along the length of the insertion guide to position the implant in the space between adjoining vertebrae, wherein the implant is slidably attached to the insertion guide by the surface configurations.





BRIEF DESCRIPTION OF THE FIGURES

The foregoing and other objects, features and advantages of the invention will be apparent from the following description and apparent from the accompanying drawings, in which like reference characters refer to the same parts throughout the different views. The drawings illustrate principles of the invention and, although not to scale, show relative dimensions



FIG. 1A-1B illustrate one embodiment of an implant having a flexible joint.



FIG. 2A-2B illustrate another embodiment of an implant a having a number of flexible joints.



FIGS. 3A-3B illustrate another embodiment of an implant having another type of flexible joint.



FIG. 4 illustrates a flow diagram for an exemplary embodiment of a method of fusing a spine using the implant of the present invention.



FIG. 5A-5B illustrate another embodiment of an implant having a number of flexible joints and surface configurations.



FIG. 6 illustrates the deformable nature of the implant of the present invention.



FIG. 7 illustrate an embodiment of the system of the present invention wherein the implant has surface configurations that slidably attach the implant to an insertion guide.



FIG. 8 illustrates a flow diagram for an exemplary embodiment of a method of fusing a spine using the system of the present invention



FIGS. 9A-9D illustrate one embodiment of how the implant of the system of the present invention is inserted by sliding the implant along the insertion guide as set forth in the exemplary embodiment of the method of FIG. 8.





DETAILED DESCRIPTION OF THE INVENTION

The present invention provides an improved surgical implant and method for performing spinal fusion surgery in a patient. The implant comprises a cage having one or more flexible joints. The cage is defined by at least a first end, second end, first side, and second side surface. The first and second side surfaces extend substantially parallel to each other to span a space between adjoining vertebrae and the first and second ends interconnect the first side surface and the second side surface. The one or more flexible joints allow the cage to be deformed for insertion into a patient. The ability to deform the cage allows a greater ease and flexibility in inserting and positioning the implant. For example, a larger implant can to be used in minimally invasive surgery (MIS) techniques because the cage can be transformed to a smaller profile to pass through the smaller access ports used in minimally invasive surgery. In certain embodiments the implant may further have surface configurations for slidably attaching the implant to a guide used to insert the implant. Embodiments of the implant and methods of use are described below.



FIGS. 1A and 1B depict one embodiment of an implant 100 for forming a rigid structure between adjoining vertebrae in a patient. In this example the implant comprises a cage 110 having first end 120, second end 130, first side 140, and second side 150 surfaces. The first 140 and second 150 side surfaces extend substantially parallel to each other to span a space between adjoining vertebrae. The first 120 and second 130 end surfaces interconnect said first side surface 140 and second side surface 150. A flexible joint 160 is incorporated into the cage allowing the cage to be deformed for insertion into a patient. FIG. 1A depicts the cage 110 of the implant in a rest state. In this example, the first 140 and second 150 side surfaces are curved giving the cage a curved kidney shape. This curvature and shape provide greater coverage and support then tradition straight-sided implants and is particularly adapted for use in a T-PLIF procedure. While, this shape provides greater biomechanical stability it makes it more difficult to insert and position due to its increased width.



FIG. 1B shows the cage 110 in a deformed state wherein the first side surface 140 has been divided or split at the flexible joint 160 giving the cage a substantially straight-sided profile. This allows the cage implant 100 to be used with traditional insertion devices configured to be used with traditional straight-sided implants.


The cage is designed to provide spacing between adjoining vertebrae while encouraging bone growth. As such, the cage 110 may be formed of any biocompatible material suitable for surgical implantation in a patient. Preferably the cage is form of a polymer or composite through a process such as injection molding. Bio-compatible metals may also be used to add strength or rigidity. Examples of suitable materials include, but are not limited to, PEAK, carbon fiber, titanium, stainless steel, Nitinol, and the like, or any combination thereof.


The cavities 170 created by the cage 110 allow the bone to grow through the cage to fuse the vertebrae. In some embodiments a substance, such as bone chips, or bone graft may be placed in the cavities 170 to encourage bone growth.


In the example of FIGS. 1A and 1B, the flexible joint 160 comprises a living hinge that is formed as part of the cage during the injection molding process. In other embodiments, the joint may not be formed as part of the cage. For example, the cage may comprise two parts that are joined together using a non-unitary joint mechanism that is embedded in or secured to the two parts. Other implementations and embodiments will be apparent to one skilled in the art given the benefit of this disclosure.



FIGS. 2A and 2B depict another embodiment of the implant 200 of the invention. As with the implant 100 of FIGS. 1A and 1B this implant 200 comprises a cage 210 having first end 220, second end 230, first side 240, and second side 250 surfaces. As in the previous embodiment, the first 240 and second 250 side surfaces are curved and extend substantially parallel to each other to span a space between adjoining vertebrae. The first 220 and second 230 end surfaces interconnect said first side surface 240 and second side surface 250 providing cavities 270 within the cage 210. However, in this embodiment, multiple flexible joints 260 are used to allow the cage to be deformed for insertion into a patient. As with FIG. 1A, FIG. 2A depicts the cage 210 of the implant 200 in a rest state with first 240 and second 250 side surfaces curved to give the cage a curved kidney shape. FIG. 2B shows the cage 210 in a deformed state wherein the first side surface 240 has been divided or split at two flexible joints 160 to give the cage a substantially straight-sided profile.


Similar to the embodiment of FIGS. 1A and 1B, the flexible joints 260 comprise living hinges that are formed as part of the cage during the injection molding process. In this example the flexible joints 260 also include a spring mechanism 280 to reinforce the living hinges and return the cage 210 to a rest state after being deformed. In this example, the spring 280 is formed of a piece of metal attached to the cage. In other embodiments, the spring 280 may be formed of plastic or a composite material. In certain embodiments, the spring 280 may be embedded in the cage 210 during the formation of the cage 210, for example, during injection molding. In other embodiments the spring 280 may be attached to the cage 210 using adhesive, rivets, or other fastening means. In certain embodiments the spring 280 may also serve as the flexible joint 260. Other embodiments and configurations will be apparent to one skilled in the art given the benefit of this disclosure.


The example of FIGS. 2A and 2B also includes an opening 225 in the first end surface 220 for receiving an instrument such as an inserter for attaching the implant to the inserter. In certain embodiments the opening 225 may be in the second end surface 230 or each end surface may have such an opening. Examples of inserters the use of inserters in conjunction with implants can be seen in WO2005077288 A1


While many of the examples and embodiments discussed in this disclosure focus on curved or kidney-shaped implants, it should be understood that the teaching of the invention are not limited to such shapes. FIGS. 3A-3B depict another example of other possible shapes and flexible joints.



FIGS. 3A and 3B are a top view depicting a straight sided square shaped implant 300. In this example, flexible joints are used to connect the first 340 and second 350 side surfaces to the first 320 and second 330 end surfaces of the cage 310. This allows the cage 310 to be transformed down to a smaller size as shown in FIG. 3B. The ability to transform the cage 310 allows the cage to be inserted through a smaller access port for insertion in between vertebrae.



FIG. 4 is a flow chart 400 of an exemplary method for fusing vertebrae of a patient. The method involves substantially the steps of providing an implant of the present invention (step 420) and inserting the implant into the space between adjoining vertebrae in a patient to form a rigid structure between the adjoining vertebrae (step 430).


In some embodiments the method 400 may further include the steps of preparing the space between adjoining vertebrae (step 410) as well as the steps of transforming the cage of the implant to a smaller profile (step 425) before implantation and transforming the cage back to the original profile after insertion (435).


The step of preparing the space between adjoining vertebrae (step 410) may include removing the disk material between the vertebrae. Then the space between the vertebrae may be distracted to relieve pressure from neural elements and provide space for the entry of surgical tools and the insertion of the implant. Preferably the surgery including the insertion is performed using a MIS technique such a T-PLIF procedure.


Because MIS techniques such as T-PLIF procedures use a more limited access port or window, the cage of the implant may need to be transformed or otherwise deformed in order to fit through the access port or window (step 425) and be positioned in the space between vertebrae. Once in position, the cage may then be transformed back or otherwise returned to its rest state (step 435). In certain embodiments this is performed by a spring incorporated or attached to the one or more flexible joints.


In some embodiments, the implant 500 may further include surface configurations 590 on at least one of the first 540 and second 550 side surfaces of the cage 510 for slidably attaching the implant 500 to an insertion guide. An example of this can be seen in FIGS. 5A and 5B. Here the surface configurations 590 are tabs or fingers formed on the first side surface 540. When used in conjunction with an insertion guide, the flexible joints 560 of the implant 500 allow the cage 510 to deform (i.e. straighten) to conform to the shape of the insertion guide. This is described in more detail below.


In the embodiments of FIGS. 5A and 5B, the cage 510 further includes textured edges 515 on the first end 520, second end 530, first side 540, and second side 550 surfaces for engaging the bone of the adjoining vertebrae to secure the implant in place in the space between vertebrae. Other possible configurations and textures for securing the implant 500 will be apparent to one skilled in the art given the benefit of this disclosure.



FIG. 6 depicts one advantage of the cage 510 of the implant being able to deform. The ability of the implant 500 of the present invention to deform allows the profile of the cage to be transformed to a smaller profile. When thus transformed, the implant can be passed through a passage smaller than what is required by a traditional curved implant 600. As shown here, the deformed (compressed) implant 500 (including surface configurations) requires only 11.9 mm of space as opposed to the 12.7 mm of space required for a fixed, non-deformable, curved implant 600 of the same size.


In another embodiment of the present invention, a system is provided for forming a rigid structure between adjoining vertebrae in a patient. An example of such a system can be seen in FIG. 7. The system 700 includes an implant 500 of the present invention as shown in FIGS. 5A and 5B having surface configurations 590 for slidably attaching the implant 500 to an insertion guide 710. As shown in this embodiment, the flexible joints 560 of the implant may allow the cage 510 to conform to the shape of the insertion guide 710. In this case the cage 510 is deformed so as to have a smaller straight-sided profile when attached to a straight portion of the insertion guide 710.


In certain embodiments, such as shown in FIG. 7, the insertion guide 710 may have a curved end 720 to further assist in the insertion and positioning of the implant 510. In use, when the implant is slid along the insertion guide 710 in the direction of arrow 730, the flexible joints 560 of the implant 500 allow the implant to curve to conform to the curved end 720 of the insertion guide 710. The implant 500 may slide along the insertion guide 710 using an inserter configured to mate with opening 525.



FIG. 8 is a flow chart 800 of an exemplary method for fusing vertebrae of a patient. The method involves substantially the steps of providing a system of the present invention having an implant with surface configurations and an insertion guide (Step 820), inserting the insertion guide into the space between adjoining vertebrae (Step 830), and sliding the implant along the length of the insertion guide to position the implant in the space between adjoining vertebrae, (Step 840).


In some embodiments the method 800 may further include the steps of preparing the space between adjoining vertebrae (Step 810) as well as the step of removing the insertion guide after the implant has been inserted (Step 850).


The step of preparing the space between adjoining vertebrae (Step 810) may include removing the disk material between the vertebrae. Then the space between the vertebrae may be distracted to relieve pressure from neural elements and provide space for the entry of surgical tools and the insertion of the implant. Preferably the surgery including the insertion is performed using a MIS technique such a T-PLIF procedure.


Examples of this methodology using a T-PLIF technique can be seen in FIG. 9A-D. Because MIS techniques such as T-PLIF procedures use a more limited access port or window 910, the insertion guide with a curved tip 720 is used to deform and guide the implant 500 so as to be inserted into and positioned in the space 920 between vertebrae as seen in FIG. 9A.


In FIG. 9B, the implant is slid along the length of the insertion guide 710. The implant 600 may be slid along the insertion guide 710 using an insertion tool (not shown) mated with the opening 525 configured to receive the insertion tool. Examples of suitable insertion devices and their use is discussed in WO2005077288 A1.


In FIG. 9C, the insertion guide 710 is used to guide the implant 500 through the access window 910 and position the implant in location in the space 920 between vertebrae. The use of the curved tip 720 allows the implant 510 to be positioned at a desired angle, preferably around 45°, even though the angle of approach through the access window 910 may be closer to 35°.


Once in position, the insertion guide 710 may be removed and the implant allowed to transform or otherwise return to its rest state as seen in FIG. 9D. In certain embodiments this is performed by a spring incorporated or attached to the one or more flexible joints.


The apparatus and techniques of the present invention provide numerous advantages. The implant of the present invention can be used in minimally invasive surgery (MIS) wherein the cage can be deformed for easier insertion and positioning through a smaller access port. In certain embodiments, the cage may have surface configurations for use with an insertion guide. The cage of the implant can be deformed to conform to the shape of the guide which allows for curved guides which in turn provide more accurate insertion and positioning.


Although, the present invention has been described relative to an illustrative embodiment and application in spinal correction surgery. It should be apparent that the present invention may be used in any number of surgical procedures. Since certain changes may be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense.


It is also to be understood that the following claims are to cover all generic and specific features of the invention described herein, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.

Claims
  • 1. An intervertebral implant comprising: a cage having one or more flexible joints incorporated into the cage that allow the cage to move between an insertion configuration and a deployed configuration and having projections formed on at least one side of the cage for attaching the cage to a guide;wherein the one or more flexible joints allow the cage to conform to a shape of a curved portion of the guide as the cage is advanced along the guide.
  • 2. The implant of claim 1, wherein the cage includes first and second lateral surfaces that are substantially parallel to each other.
  • 3. The implant of claim 2, wherein when the cage is in the deployed configuration, the first and second lateral surfaces are curved.
  • 4. The implant of claim 3, wherein when the cage is in the insertion configuration, the first and second lateral surfaces are straight.
  • 5. The implant of claim 1, wherein the projections are configured to slidably couple to the guide such that the cage can slide along the guide.
  • 6. The implant of claim 1, wherein the one or more flexible joints comprise a living hinge.
  • 7. The implant of claim 1, wherein the one or more flexible joints comprise a spring mechanism.
  • 8. The implant of claim 1, further comprising a spring mechanism disposed along first or second side surfaces of the cage.
  • 9. The implant of claim 1, wherein the projections extend from at least one of first and second sides of the cage.
  • 10. The implant of claim 1, wherein the projections extend from first and second surfaces of the cage.
  • 11. A spinal fusion system comprising: a cage having one or more joints that facilitate insertion of the cage into an intervertebral space, the cage having protrusions extending out of at least one surface of the cage for attaching the cage to a side of an insertion guide and for allowing the cage to slide along the insertion guide; andan insertion guide configured to interface with the protrusions of the cage;wherein the insertion guide and the one or more joints of the cage allow the cage to follow a curved path as the cage slides along the insertion guide within the intervertebral space.
  • 12. The system of claim 11, wherein the one or more joints allow the cage to conform to a shape of the insertion guide.
  • 13. The system of claim 11, wherein the insertion guide has a curved portion that defines the curved path of the cage.
  • 14. The system of claim 13, wherein the guide further comprises a straight portion that is proximal to the curved portion.
  • 15. The system of claim 11, wherein the protrusions comprise first and second protrusions disposed on opposite sides of one of the joints.
  • 16. The system of claim 11, wherein the protrusions extend from first and second surfaces of the cage, the first and second surfaces being substantially parallel.
  • 17. The system of claim 11, wherein the insertion guide is configured to be positioned within the intervertebral space before the cage is advanced therealong.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/574,441, filed Dec. 18, 2014, which is a continuation of U.S. patent application Ser. No. 14/053,821, filed Oct. 15, 2013, now issued as U.S. Pat. No. 8,936,643 on Jan. 20, 2015, which is a continuation of U.S. patent application Ser. No. 13/230,163, filed Sep. 12, 2011, now issued as U.S. Pat. No. 8,579,983 on Nov. 12, 2013, titled “SPINAL FUSION IMPLANT,” which is a continuation of and claims priority to and the benefit of U.S. patent application Ser. No. 11/496,564, titled “SPINAL FUSION IMPLANT”, which was filed on Jul. 31, 2006, now issued as U.S. Pat. No. 8,034,110 on Oct. 11, 2011. The above-identified applications are hereby incorporated by reference in their entirety as though fully set forth herein.

US Referenced Citations (193)
Number Name Date Kind
2115250 Bruson Apr 1938 A
2170111 Bruson Aug 1939 A
2229024 Bruson Jan 1941 A
2706701 Beller et al. Apr 1955 A
2710277 Shelanski et al. Jun 1955 A
2826532 Hosmer Mar 1958 A
2900305 Siggia Aug 1959 A
2977315 Scheib et al. Mar 1961 A
3228828 Romano Jan 1966 A
3717655 Godefroi et al. Feb 1973 A
4352883 Lim Oct 1982 A
4440921 Allcock et al. Apr 1984 A
4495174 Allcock et al. Jan 1985 A
4645503 Lin et al. Feb 1987 A
4743256 Brantigan May 1988 A
4772287 Ray et al. Sep 1988 A
4834757 Brantigan May 1989 A
4863476 Shepperd Sep 1989 A
4871366 von Recum et al. Oct 1989 A
4878915 Brantigan Nov 1989 A
4880622 Allcock et al. Nov 1989 A
5059193 Kuslich Oct 1991 A
5133755 Brekke Jul 1992 A
5192327 Brantigan Mar 1993 A
5390683 Pisharodi Feb 1995 A
5397364 Kozak et al. Mar 1995 A
5410016 Hubbell et al. Apr 1995 A
5425772 Brantigan Jun 1995 A
5443514 Steffee Aug 1995 A
5522895 Mikos Jun 1996 A
5522899 Michelson Jun 1996 A
5549679 Kuslich Aug 1996 A
5554191 Lahille Sep 1996 A
5562736 Ray et al. Oct 1996 A
5658335 Allen Aug 1997 A
5665122 Kambin Sep 1997 A
5679723 Cooper et al. Oct 1997 A
5702449 McKay Dec 1997 A
5716415 Steffee Feb 1998 A
5782832 Larsen et al. Jul 1998 A
5800549 Bao et al. Sep 1998 A
5807327 Green et al. Sep 1998 A
5824084 Muschler Oct 1998 A
5833657 Reinhardt et al. Nov 1998 A
5837752 Shastri et al. Nov 1998 A
5860973 Michelson Jan 1999 A
5865848 Baker Feb 1999 A
5888220 Felt et al. Mar 1999 A
5888227 Cottle Mar 1999 A
5972385 Liu et al. Oct 1999 A
5984922 McKay Nov 1999 A
5985307 Hanson et al. Nov 1999 A
6039761 Li et al. Mar 2000 A
6045579 Hochshuler et al. Apr 2000 A
6071982 Wise et al. Jun 2000 A
6113624 Bezwada et al. Sep 2000 A
6113638 Williams et al. Sep 2000 A
6126689 Brett Oct 2000 A
6129763 Chauvin et al. Oct 2000 A
6147135 Yuan et al. Nov 2000 A
6165486 Marra et al. Dec 2000 A
6171610 Vacanti et al. Jan 2001 B1
6176882 Biedermann et al. Jan 2001 B1
6187048 Milner et al. Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6197325 MacPhee et al. Mar 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6206923 Boyd et al. Mar 2001 B1
6214368 Lee et al. Apr 2001 B1
6224631 Kohrs May 2001 B1
6224894 Jamiolkowski et al. May 2001 B1
6245108 Biscup Jun 2001 B1
6248131 Felt et al. Jun 2001 B1
6264695 Stoy Jul 2001 B1
6277149 Boyle et al. Aug 2001 B1
6280474 Cassidy et al. Aug 2001 B1
6306177 Felt et al. Oct 2001 B1
6325827 Lin Dec 2001 B1
6331312 Lee et al. Dec 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6368325 McKinley et al. Apr 2002 B1
6368351 Glenn et al. Apr 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6387130 Stone et al. May 2002 B1
6413278 Marchosky Jul 2002 B1
6436140 Liu et al. Aug 2002 B1
6494883 Ferree Dec 2002 B1
6533818 Weber et al. Mar 2003 B1
6558424 Thalgott May 2003 B2
6562072 Fuss et al. May 2003 B1
6562074 Gerbec et al. May 2003 B2
6582431 Ray Jun 2003 B1
6592625 Cauthen Jul 2003 B2
6595998 Johnson et al. Jul 2003 B2
6610094 Husson Aug 2003 B2
6632235 Weikel et al. Oct 2003 B2
6669732 Serhan et al. Dec 2003 B2
6676703 Biscup Jan 2004 B2
6689132 Biscup Feb 2004 B2
6719794 Gerber et al. Apr 2004 B2
6805697 Helm et al. Oct 2004 B1
6833006 Foley et al. Dec 2004 B2
6835208 Marchosky Dec 2004 B2
6974480 Messerli et al. Dec 2005 B2
6979352 Reynolds Dec 2005 B2
7326248 Michelson Feb 2008 B2
7500991 Bartish, Jr. et al. Mar 2009 B2
7503920 Siegal Mar 2009 B2
7517363 Rogers et al. Apr 2009 B2
7520900 Trieu Apr 2009 B2
7575580 Lim et al. Aug 2009 B2
7655010 Serhan et al. Feb 2010 B2
7666266 Izawa et al. Feb 2010 B2
7670374 Schaller Mar 2010 B2
7785368 Schaller Aug 2010 B2
7799083 Smith et al. Sep 2010 B2
7918874 Siegal Apr 2011 B2
7935051 Miles et al. May 2011 B2
7942903 Moskowitz et al. May 2011 B2
8007535 Hudgins et al. Aug 2011 B2
8034110 Garner et al. Oct 2011 B2
8057544 Schaller Nov 2011 B2
8206423 Siegal Jun 2012 B2
8343193 Johnson et al. Jan 2013 B2
8382842 Greenhalgh et al. Feb 2013 B2
8403990 Dryer et al. Mar 2013 B2
8454617 Schaller et al. Jun 2013 B2
8579981 Lim et al. Nov 2013 B2
8579983 Garner et al. Nov 2013 B2
8845734 Weiman Sep 2014 B2
8900307 Hawkins et al. Dec 2014 B2
8926704 Glerum et al. Jan 2015 B2
8936643 Garner et al. Jan 2015 B2
20010039452 Zucherman et al. Nov 2001 A1
20010039453 Gresser et al. Nov 2001 A1
20020029084 Paul et al. Mar 2002 A1
20020045904 Fuss et al. Apr 2002 A1
20020055781 Sazy May 2002 A1
20020058947 Hochschuler et al. May 2002 A1
20020077701 Kuslich Jun 2002 A1
20020107573 Steinberg Aug 2002 A1
20020173796 Cragg Nov 2002 A1
20020193883 Wironen Dec 2002 A1
20020198526 Shaolian et al. Dec 2002 A1
20030028251 Mathews Feb 2003 A1
20030093153 Banick et al. May 2003 A1
20030135275 Garcia et al. Jul 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20040002761 Rogers et al. Jan 2004 A1
20040049270 Gewirtz Mar 2004 A1
20040087947 Lim et al. May 2004 A1
20040116997 Taylor et al. Jun 2004 A1
20040127990 Bartish et al. Jul 2004 A1
20040167538 Gerber et al. Aug 2004 A1
20040220669 Studer Nov 2004 A1
20040230309 DiMauro et al. Nov 2004 A1
20050019365 Frauchiger et al. Jan 2005 A1
20050119752 Williams et al. Jun 2005 A1
20050261682 Ferree Nov 2005 A1
20060036273 Siegal Feb 2006 A1
20060041258 Galea Feb 2006 A1
20060122701 Kiester Jun 2006 A1
20060129244 Ensign Jun 2006 A1
20060142858 Colleran Jun 2006 A1
20060235426 Lim et al. Oct 2006 A1
20070067035 Falahee Mar 2007 A1
20070178222 Storey et al. Aug 2007 A1
20080058933 Garner et al. Mar 2008 A1
20080188945 Boyce et al. Aug 2008 A1
20080221586 Garcia-Bengochea et al. Sep 2008 A1
20090216234 Farr et al. Aug 2009 A1
20100076502 Guyer et al. Mar 2010 A1
20110029083 Hynes et al. Feb 2011 A1
20110029085 Hynes et al. Feb 2011 A1
20110098818 Brodke et al. Apr 2011 A1
20110125266 Rodgers et al. May 2011 A1
20110319898 O'Neil et al. Dec 2011 A1
20110319998 O'Neil et al. Dec 2011 A1
20110320000 O'Neil et al. Dec 2011 A1
20110320002 Garner et al. Dec 2011 A1
20120310352 DiMauro et al. Dec 2012 A1
20130190875 Shulock et al. Jul 2013 A1
20140052259 Garner et al. Feb 2014 A1
20140277481 Lee et al. Sep 2014 A1
20150094812 Cain Apr 2015 A1
20150105860 Garner et al. Apr 2015 A1
20150112437 Davis et al. Apr 2015 A1
20150164655 DiMauro Jun 2015 A1
20150173914 DiMauro et al. Jun 2015 A1
20150196401 DiMauro et al. Jul 2015 A1
20150202052 DiMauro Jul 2015 A1
20150216673 DiMauro Aug 2015 A1
20160000577 DiMauro Jan 2016 A1
Foreign Referenced Citations (10)
Number Date Country
9317669 Sep 1993 WO
9726847 Jul 1997 WO
9834568 Aug 1998 WO
9902214 Jan 1999 WO
0217825 Mar 2002 WO
03002021 Jan 2003 WO
03005937 Jan 2003 WO
2005077288 Aug 2005 WO
2010075555 Jul 2010 WO
2012027490 Mar 2012 WO
Non-Patent Literature Citations (39)
Entry
Supplementary European Search Report for Application No. 07836359.5, dated Aug. 29, 2011.
International Search Report and Written Opinion for Application No. PCT/US07/17100, dated Aug. 11, 2008.
International Preliminary Report on Patentability for Application No. PCT/US07/17100, issued Feb. 3, 2009 (9 pages).
[No Author Listed] FDA Approves Cambridge Scientific, Inc.'s Orthopedic WISORB (TM) Malleolar Screw [online], Jul. 30,2002, 5 pages. Retrieved from the Internet <URL: http://www.cambridgescientificinc.com/interbody.htm>, [retrieved on Oct. 14, 2003].
[No Author Listed] Longer BAK/L Sterile Interbody Fusion Devices. Date believed to be 1997. Product Data Sheet. Zimmer. Retrieved Jul. 23, 2012 from <http://catalog.zimmer.com/content/zpc/products/600/600/620/S20/S045.html>. 2 pages.
[No Author Listed] Osteoset® DBM Pellets (Important Medical Information) [online], Nov. 2002, 5 pages. Retrieved from the Internet <URL: http://www.wmt.com/Literature>, [retrieved on Oct. 14, 2003].
[No Author Listed] Sonic Accelerated Fracture Healing System/Exogen 3000. Premarket Approval, U.S. Food & Drug Administration. Date believed to be May 10, 2000, 4 pages. Retrieved Jul. 23, 2012 from <http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=14736#>.
Barakat et al., 1996.
Bruder et al., Identification and characterization of a cell surface differentiation antigen on human osteoprogenitor cells. 42nd Annual Meeting of the Orthopaedic Research Society. p. 574, Feb. 19-22, 1996, Atlanta, Georgia.
Bruder et al., Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone. Sep. 1997;21(3):225-235.
Burkoth et al., A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials. Dec. 2000;21(23):2395-2404.
Cheng, B.C., Ph.D., Biomechanical pullout strength and histology of Plasmapore® XP coated implants: Ovine multi time point survival study. Aesculap Implant Systems, LLC, 2013, 12 pages.
Domb, 1996.
Flemming et al., Monoclonal anitbody against adult marrow-derived mesenchymal stem cells recognizes developing vasculature in embryonic human skin. Developmental Dynamics. 1998;212:119-132.
Gennaro, A.R., ed., Remington: The Science and Practice of Pharmacy. Williams & Wilkins, 19th edition, Jun. 1995.
Haas, Norbert P., New Products from AO Development [online], May 2002, 21 pages. Retrieved from the Internet <URL:http://www.ao.asif.ch/development/pdf—tk—news—02.pdf>, [retrieved on Oct. 14, 2003].
Hao et al., Investigation of nanocomposites based on semi-interpenetrating network of [L-poly (epsilon-caprolactone)]/ [net-poly (epsilon-caprolactone)] and hydroxyapatite nanocrystals. Biomaterials Apr. 2003;24(9):1531-9.
Haynesworth et al., Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13(1):69-80.
Hitchon et al., Comparison of the biomechanics of hydroxyapatite and polymethylmethacrylate vertebroplasty in a cadaveric spinal compression fracture model. J Neurosurg. Oct. 2001;95(2 Suppl):215-20.
Invitation to Pay Additional Fees mailed Aug. 10, 2004 for Application No. PCT/US2004/004284 (8 Pages).
International Search Report and Written Opinion mailed Oct. 29, 2004 for Application No. PCT/US2004/004284 (17 Pages).
International Preliminary Report on Patentability mailed Feb. 15, 2005 for Application No. PCT/US2004/004284 (8 Pages).
Kandziora, Frank, et al., “Biomechanical Analysis of Biodegradable Interbody Fusion Cages Augmented with Poly (propylene Glycol-co-Fumaric Acid),” SPINE, 27(15): 1644-1651 (2002).
Kotsias, A., Clinical trial of titanium-coated PEEL cages anterior cervical discectomy and fusion. [Klinishe Untersuching zum Einsatz von titanbeschichteten Polyetheretherketon-Implantaten bei der cervikalen interkorporalen [fusion]. Doctoral thesis. Department of Medicine, Charite, University of Medicine Berlin, 2014, 73 pages. German language document. English Abstract Only.
Kricheldorf and Kreiser-Saunders, 1996.
Kroschwitz et al., eds., Hydrogels. Concise Encyclopedia of Polymer Science and Engineering. Wiley and Sons, pp. 458-459, 1990.
Lange, A.L., Lange's Handbook of Chemistry. McGraw-Hill Inc., 13th edition, Mar. 1985.
Lendlein et al., AB-polymer networks based on oligo(epsilon-caprolactone) segments showing shape-memory properties. Proc Natl Acad Sci U S A. Jan. 30, 2001;98(3):842-7. Epub Jan. 23, 2001.
Malberg, M.I., MD; Pimenta, L., MD; Millan, M.M., MD, 9th International Meeting on Advanced Spine Techniques, May 23-25, 2002, Montreux, Switzerland. Paper #54, Paper #60, and E-Poster #54, 5 pages.
Massia and Hubbell, 1991.
McAfee et al., Minimally invasive anterior retroperitoneal approach to the lumbar spine: Emphasis on the lateral BAK. SPINE 1998;23(13):1476-84.
Mendez et al., Self-curing acrylic formulations containing PMMA/PCL composites: properties and antibiotic release behavior. J Biomed Mater Res. Jul. 2002;61(1):66-74.
New Zealander Office Action issued Jul. 9, 2007 for Application No. 541626 (3 Pages).
Regan et al., Endoscopic thoracic fusion cage. Atlas of Endoscopic Spine Surgery. Quality Medical Publishing, Inc. 1995;350-354.
Slivka et al., In vitro compression testing of fiber-reinforced, bioabsorbable, porous implants. Synthetic Bioabsorbable Polymers for Implants. STP1396, pp. 124-135, ATSM International, Jul. 2000.
Stewart et al., Co-expression of the stro-1 anitgen and alkaline phosphatase in cultures of human bone and marrow cells. ASBMR 18th Annual Meeting. Bath Institute for Rheumatic Diseases, Bath, Avon, UK., p. S142, 1996.
Timmer et al., In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials. Feb. 2003;24(4):571-7.
United States Disctrict Court, Central District of California, Case No. 1:10-CV-00849-LPS, Nuvasive, Inc., vs., Globus Medical, Inc., Videotaped Deposition of: Luiz Pimenta, M.D., May 9, 2012, 20 pages.
Walsh et al., Preparation of porous composite implant materials by in situ polymerization of porous apatite containing epsilon-caprolactone or methyl methacrylate. Biomaterials. Jun. 2001;22(11):1205-12.
Related Publications (1)
Number Date Country
20150265419 A1 Sep 2015 US
Continuations (4)
Number Date Country
Parent 14574441 Dec 2014 US
Child 14723580 US
Parent 14053821 Oct 2013 US
Child 14574441 US
Parent 13230163 Sep 2011 US
Child 14053821 US
Parent 11496564 Jul 2006 US
Child 13230163 US